Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. - Wikidata - awgldk - TriplyDB

Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.

Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.

http://www.wikidata.org/entity/Q35218379

about

Docosahexaenoic Acid and Cognition throughout the Lifespan Peroxisomes in brain development and function Choline plasmalogens isolated from swine liver inhibit hepatoma cell proliferation associated with caveolin-1/Akt signaling Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin.Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.PPAR- γ impairment alters peroxisome functionality in primary astrocyte cell cultures.APP Function and Lipids: A Bidirectional Link.Lipidomics of Alzheimer's disease: current status.Lipid metabolism in Alzheimer's disease Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.Neuroprotective Actions of Dietary Choline.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.Biomarkers and evolution in Alzheimer disease.Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging.

P2860

Q26768442-9FD49FD5-D9F4-42A8-83D5-E933DB4CA83B Q26774697-A9E3B95D-4B80-44F8-ADA7-7682B0813AA0 Q28534403-D00E0A88-32BB-472B-9E68-54B0D910B612 Q33806815-CC20C09A-0B29-4A87-B3AC-1D73BF724BF2 Q35742545-2CF769AB-BAEF-43AC-82F9-B4C7AA8FDE29 Q35844193-D51ADB18-A1A8-4A00-9071-38B3F7C25898 Q35993891-C8C76673-D561-46CC-ADA9-00B92C5DA68F Q36188186-C7F23A0C-CD18-4276-99E7-9AC852BB2940 Q36306413-CD7DF2C6-F144-4937-BAD3-C39AECBCD1B0 Q36590043-34EF31DB-F0CF-4456-A453-8A95CC99B251 Q36750552-EE045EE2-7104-486D-9BD4-72478FD45D2E Q37650379-02BE8F5C-CFDA-4B7A-B859-2ED8F2E2AE8A Q37692220-AB5E3E8D-5A7F-44A4-A7C4-8894AFAF429F Q37980283-8D236C56-58A1-4291-AD52-C79456C29130 Q38204719-984BFF87-B3D3-47EF-B676-5270978EBDF2 Q39320214-F63D10B6-856D-4554-9149-C408B99D0146 Q39928314-3B7E0C98-29FB-4F04-85DA-1CD20BB771EB Q41583852-28FA069B-559E-4BAB-AD63-BC423024BB64 Q42655692-9360D5F1-2CA4-4223-BF61-A272D9221DF1 Q48159157-EF0560A1-7D6A-4542-8EC8-9C30D544F8D9 Q48985565-4A65D4DD-8BD2-415E-B3E1-BDAA55C48BC8 Q50417000-4ACA2CA7-6D06-45F3-B845-B808A2C23773 Q54878401-6AEF7C5F-C66E-4826-A8C7-9944F8461E33

P2860

Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.

http://www.wikidata.org/entity/Q35218379

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@ast

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@en

type

label

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@ast

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@en

prefLabel

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@ast

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@en

P1433

Q35218379-52B49288-7A97-4368-9953-7C664B955CA9

P1476

Q35218379-1AE02D95-408E-46C4-AE15-080C6E611E1C

P2093

Q35218379-3AEC70BB-7B91-447D-B9DA-749B9B749FD9

Q35218379-4D58438E-953A-455E-A23F-FE7209D867D6

Q35218379-7988A022-8F9A-452A-B7CE-20DFA4642A94

Q35218379-A765D97A-DAC0-40E6-8593-215CFC8CA9CE

Q35218379-C06ADD4C-14DD-42B5-817D-BB1272176352

P2860

Q35218379-03B01782-E66D-40E2-BABE-26971EF79402

Q35218379-0B1E33B4-FC98-44B2-A9DB-D98277F5856E

Q35218379-0E76516B-02AD-47D3-BC0D-6B975379E996

Q35218379-12A6BF36-CCE6-4F62-A167-88CD017854EC

Q35218379-1387D671-10B8-4DDD-8D79-06613A2D7D33

Q35218379-15DEAD21-4693-43AF-A7BA-66EE422D9925

Q35218379-16F259FD-B8D0-4AF9-8183-DD223495E36E

Q35218379-1A4596FB-A671-43C3-A105-43CB287D1596

Q35218379-1AAADF45-DBE7-43A7-AC10-BC94CD148A9B

Q35218379-1BC68443-D7A4-4536-9A83-F6DE0AAC582B

P304

Q35218379-58681ED9-20D9-4327-AFE1-13BC2EC0A27F

P31

Q35218379-CCFDEA47-5FDA-4021-9D88-AD7C88D3036F

P356

Q35218379-0BDDA5B3-42D0-4271-BB66-04D9795B5A83

P433

Q35218379-9DDF297C-8A16-4313-89B0-AECE93DCC19A

P478

Q35218379-EAAEFBFA-5205-47A9-B933-D578DD780CE2

P50

Q35218379-5FC7CE9E-88F4-45D2-9DE4-14823258A8C8

Q35218379-78539C8E-4E79-448E-A486-30736B29BCB5

P577

Q35218379-0D7E872D-FF22-434E-8342-6CED208B6833

P698

Q35218379-D81DF669-07CE-4C30-B848-88EE4FDCE616

P921

Q35218379-A3B9C449-994C-4C16-BD3C-9AA2E018A2D5

Q35218379-FD03B18F-88D2-4FB3-A18E-CE20B85EAE45

P932

Q35218379-772EE41B-B1A6-46E0-B1AF-A1F8203BA460

P356

JAD-2011-101608

P1433

Journal of Alzheimer's Disease

P1476

Disturbed choline plasmalogen ...... r's disease prefrontal cortex.

@en

P2093

Fei Gao

http://www.w3.org/2001/XMLSchema#string

Hyung-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Jagadeesh S Rao

http://www.w3.org/2001/XMLSchema#string

Kaizong Ma

http://www.w3.org/2001/XMLSchema#string

Miki Igarashi

http://www.w3.org/2001/XMLSchema#string

P2860

Bipolar disorder and mechanisms of action of mood stabilizers

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

Arachidonic acid and the brain

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

A simple method for the isolation and purification of total lipides from animal tissues

Diversity of group types, regulation, and function of phospholipase A2

Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?

Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation?

Evidence for a membrane defect in Alzheimer disease brain

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

P304

507-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2011-101608

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Stanley I. Rapoport

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21297269

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3175096

http://www.w3.org/2001/XMLSchema#string